NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Non Operating Interest Expenses (2019 - 2020)

Updated

NovaBridge Biosciences (NBP) recorded Non Operating Interest Expenses of $102,000 in FY2023, compared with $1,000 in FY2022.

Analysis

NovaBridge Biosciences (NBP) Non Operating Interest Expenses (2019 - 2020) Analysis & Trends

Starting with FY2017, NovaBridge Biosciences' Non Operating Interest Expenses history includes 6 years.

  • Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -43.5% (FY2018 to FY2023).
  • The FY2023 figure is the highest annual Non Operating Interest Expenses since FY2020.
  • Per Business Quant data, NBP's Non Operating Interest Expenses was $1,000 in FY2022, $147,000 in FY2020 (-65.8%) and $430,000 in FY2019 (-75.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 276,532.85
Dec 31, 2019 74,487.40
Sep 30, 2019 628,027.28
API Access

NovaBridge Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=NBP&period=max&api_key=YOUR_API_KEY